Background: Recurring nodules, abscesses, and lesions characterise hidradenitis suppurativa (HS): a chronic, inflammatory skin disorder. Globally the prevalence of HS is estimated to be around 1% of the population. Leakage, pain, and odour from HS wounds require substantial management. Little is known of the personal burdens that routine wound management imposes on the patient. Objectives: To evaluate how routine HS wound management impacts patients in terms of the time spent changing dressings, the number of dressings required per day, pain experienced during dressing changes, and negative impact on various domains of their personal lives. Methods: An anonymous online questionnaire was posted on closed social media patient support groups between April and May 2019. Pearson χ2 test was used to evaluate if Hurley stages influenced the personal impact of wound care routines on patients. Statistical significance was determined as p value <0.05. Results: In total, 908 people from 28 countries responded. Of these, 81% (n = 734) reported that regular dressing changes negatively impacted on their quality of life. Most patients, 82% (n = 744), experience pain during dressing changes. 16% (n = 142) of patients required five or more dressings daily, and 12% (n = 108) spend over 30 min daily tending to wounds. Patients indicated high levels of dissatisfaction with currently available wound dressings. Conclusion: HS wound management imposes a substantial personal burden on patients. There is a clear unmet need for HS-specific wound dressings and wound care provisions, and a greater awareness of the condition and its impact is needed among clinicians.

1.
Gillespie
P
,
Carter
L
,
McIntosh
C
,
Gethin
G
.
Estimating the health-care costs of wound care in Ireland
.
J Wound Care
.
2019
;
28
:
324
30
. .
2.
Olsson
M
,
Järbrink
K
,
Divakar
U
,
Bajpai
R
,
Upton
Z
,
Schmidtchen
A
,
The humanistic and economic burden of chronic wounds: A systematic review
.
Wound Repair Regen
.
2019 Jan
;
27
(
1
):
114
25
. .
3.
Erfurt-Berge
C
,
Ronicke
M
,
Richter-Schmidinger
T
,
Walther
F
,
Renner
R
.
Quality of life assessment in family members of patients with chronic wounds
.
Eur J Dermatol
.
2019Oct 1
;
29
(
5
):
484
9
. .
4.
Sabat
R
,
Jemec
GBE
,
Matusiak
Ł
,
Kimball
AB
,
Prens
E
,
Wolk
K
.
Hidradenitis suppurativa
.
Nat Rev Dis Primers
.
2020 Mar
;
6
(
6
):
18
. .
5.
Antia
C
,
Alavi
A
,
Alikhan
A
.
Topical management and wound care approaches for hidradenitis suppurativa
.
Semin Cutan Med Surg
.
2017 Jun
;
36
(
2
):
58
61
. .
6.
Alavi
A
,
Sibbald
RG
,
Kirsner
RS
.
Optimal hidradenitis suppurativa topical treatment and wound care management: a revised algorithm
.
J Dermatolog Treat
.
2018 Jun
;
29
(
4
):
383
4
. .
7.
Braunberger
TL
,
Fatima
S
,
Vellaichamy
G
,
Nahhas
AF
,
Parks-Miller
A
,
Hamzavi
IH
.
Dress for Success: a Review of Dressings and Wound Care in Hidradenitis Suppurativa
.
Curr Derm Rep
.
2018
;
7
(
4
):
269
77
. .
8.
Ali
AAA
,
Lowes
MA
,
Alavi
A
.
Wound Healing in Hidradenitis Suppurativa
. In:
Alavi
A
,
Maibach
HI
, editors.
Local Wound care for Dermatologists
;
2020
. p.
177
86
. .
9.
Hendricks
AJ
,
Hsiao
JL
,
Lowes
MA
,
Shi
VY
.
A Comparison of International Management Guidelines for Hidradenitis Suppurativa
.
Dermatology
.
2019 Oct 23
:
1
16
. .
10.
Alavi
A
,
Lynde
C
,
Alhusayen
R
,
Bourcier
M
,
Delorme
I
,
George
R
,
Approach to the Management of Patients With Hidradenitis Suppurativa: A Consensus Document
.
J Cutan Med Surg
.
2017 Nov/Dec
;
21
(
6
):
513
24
. .
11.
Zouboulis
CC
,
Desai
N
,
Emtestam
L
,
Hunger
RE
,
Ioannides
D
,
Juhász
I
,
European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa
.
J Eur Acad Dermatol Venereol
.
2015 Apr
;
29
(
4
):
619
44
. .
12.
Magalhães
RF
,
Rivitti-Machado
MC
,
Duarte
GV
,
Souto
R
,
Nunes
DH
,
Chaves
M
,
Consensus on the treatment of hidradenitis suppurativa - Brazilian Society of Dermatology
.
An Bras Dermatol
.
2019 Apr
;
94
(
2 Suppl 1
):
7
19
. .
13.
Lindholm
C
,
Searle
R
.
Wound management for the 21st century: combining effectiveness and efficiency
.
Int Wound J
.
2016 Jul
;
13 Suppl 2
(
Suppl 2
):
5
15
. .
14.
Jørgensen
S
,
Nygaard
R
,
Posnett
J
.
Meeting the challenges of wound care in Danish home care
.
J Wound Care
.
2013 Oct
;
22
(
10
):
540544
25
.
15.
Tugnoli
S
,
Agnoli
C
,
Silvestri
A
,
Giari
S
,
Bettoli
V
,
Caracciolo
S
.
Anger, Emotional Fragility, Self-esteem, and Psychiatric Comorbidity in Patients with Hidradenitis Suppurativa/Acne Inversa
.
J Clin Psychol Med Settings
.
2019 Jun 20
.
16.
Kirby
JS
,
Sisic
M
,
Tan
J
.
Exploring Coping Strategies for Patients with Hidradenitis Suppurativa
.
JAMA Dermatol
.
2016 Oct 1
;
152
(
10
):
1166
7
. .
17.
Kouris
A
,
Platsidaki
E
,
Christodoulou
C
,
Efstathiou
V
,
Dessinioti
C
,
Tzanetakou
V
,
Quality of Life and Psychosocial Implications in Patients with Hidradenitis Suppurativa
.
Dermatology
.
2016
;
232
(
6
):
687
91
. .
18.
Sandhu
VK
,
Shah
M
,
Piguet
V
,
Alavi
A
.
The impact of hidradenitis suppurativa on work productivity and activity impairment
.
Br J Dermatol
.
2020 May
;
182
(
5
):
1288
90
. .
19.
Tzellos
T
,
Yang
H
,
Mu
F
,
Calimlim
B
,
Signorovitch
J
.
Impact of hidradenitis suppurativa on work loss, indirect costs and income
.
Br J Dermatol
.
2019 Jul
;
181
(
1
):
147
54
. .
20.
Yao
Y
,
Jørgensen
AR
,
Thomsen
SF
.
Work productivity and activity impairment in patients with hidradenitis suppurativa: a cross-sectional study
.
Int J Dermatol
.
2020 Mar
;
59
(
3
):
333
40
. .
21.
Janse
IC
,
Deckers
IE
,
van der Maten
AD
,
Evers
AWM
,
Boer
J
,
van der Zee
HH
,
Sexual health and quality of life are impaired in hidradenitis suppurativa: a multicentre cross-sectional study
.
Br J Dermatol
.
2017 Apr
;
176
(
4
):
1042
7
. .
22.
Cuenca-Barrales
C
,
Ruiz-Villaverde
R
,
Molina-Leyva
A
.
Sexual Distress in Patients with Hidradenitis Suppurativa: A Cross-Sectional Study
.
J Clin Med
.
2019 Apr 18
;
8
(
4
):
532
. .
23.
Serena
T
,
Yaakov
R
,
Aslam
S
,
Aslam
R
.
Preventing, minimizing, and managing pain in patients with chronic wounds: challenges and solutions
.
Cwcmr
.
2016
;
Volume 3
:
85
90
. .
24.
McNichol
L
,
Lund
C
,
Rosen
T
,
Gray
M
.
Medical adhesives and patient safety: state of the science: consensus statements for the assessment, prevention, and treatment of adhesive-related skin injuries
.
J Wound Ostomy Continence Nurs
.
2013
;
40
:
365
2
. .
25.
Drew
P
,
Posnett
J
,
Rusling
L
.
The cost of wound care for a local population in England
.
Int Wound J
.
2007
;
4
:
149
55
. .
26.
Sen
C
.
Human Wounds and Its Burden. An Updated Compendium of Estimates
.
Adv Wound Care (New Rochelle)
.
2019 Feb 1
;
8
(
2
):
39
48
.
27.
Ring
HC
,
Randskov Vinding
G
,
Miller
IM
,
Jemec
GB
.
Time Spent per delta PASI (TSdP) among psoriasis patients undergoing UVB-therapy – A pilot study
.
J Dermatolog Treat
.
2015 Oct
;
26
(
5
):
415
7
. .
28.
Lindsø Andersen
P
,
Jemec
GB
,
Saunte
DML
.
Treatment adherence and psychosocial impact of tinea capitis in families: Qualitative pilot study
.
Dermatol Ther
.
2020 Jul
;
33
(
4
):
e13570
.
29.
Verboom
P
,
Hakkaart-Van
L
,
Sturkenboom
M
,
De Zeeuw
R
,
Menke
H
,
Rutten
F
.
The cost of atopic dermatitis in the Netherlands: an international comparison
.
Br J Dermatol
.
2002 Oct
;
147
(
4
):
716
24
. .
30.
Kazemi
A
,
Carnaggio
K
,
Clark
M
,
Shephard
C
,
Okoye
GA
.
Optimal wound care management in hidradenitis suppurativa
.
J Dermatolog Treat
.
2018 Mar
;
29
(
2
):
165
7
. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.